Neurobo Pharmaceuticals Volatility
| NRBODelisted Stock | USD 2.36 0.01 0.43% |
Neurobo Pharmaceuticals has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. Neurobo Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neurobo Pharmaceuticals' Standard Deviation of 4.8, mean deviation of 3.35, and Risk Adjusted Performance of (0.07) to check out the risk estimate we provide. Key indicators related to Neurobo Pharmaceuticals' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Neurobo Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Neurobo daily returns, and it is calculated using variance and standard deviation. We also use Neurobo's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Neurobo Pharmaceuticals volatility.
Neurobo |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Neurobo Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Neurobo Pharmaceuticals at lower prices. For example, an investor can purchase Neurobo stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Neurobo Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Neurobo Stock
Moving against Neurobo Stock
| 0.86 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.81 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.78 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.74 | GILD | Gilead Sciences | PairCorr |
| 0.72 | BHC | Bausch Health Companies | PairCorr |
| 0.64 | WAT | Waters | PairCorr |
| 0.59 | EBS | Emergent Biosolutions | PairCorr |
| 0.54 | BCTXW | BriaCell Therapeutics | PairCorr |
| 0.52 | VTRS | Viatris | PairCorr |
Neurobo Pharmaceuticals Market Sensitivity And Downside Risk
Neurobo Pharmaceuticals' beta coefficient measures the volatility of Neurobo stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Neurobo stock's returns against your selected market. In other words, Neurobo Pharmaceuticals's beta of 0.19 provides an investor with an approximation of how much risk Neurobo Pharmaceuticals stock can potentially add to one of your existing portfolios. Neurobo Pharmaceuticals exhibits very low volatility with skewness of 1.47 and kurtosis of 4.07. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Neurobo Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Neurobo Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Neurobo Pharmaceuticals Demand TrendCheck current 90 days Neurobo Pharmaceuticals correlation with market (Dow Jones Industrial)Neurobo Beta |
Neurobo standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.82 |
It is essential to understand the difference between upside risk (as represented by Neurobo Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Neurobo Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in neurobo stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Neurobo Pharmaceuticals.
Neurobo Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Neurobo Pharmaceuticals delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Neurobo Pharmaceuticals' price changes. Investors will then calculate the volatility of Neurobo Pharmaceuticals' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Neurobo Pharmaceuticals' volatility:
Historical Volatility
This type of delisted stock volatility measures Neurobo Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Neurobo Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Neurobo Pharmaceuticals' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Neurobo Pharmaceuticals' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Neurobo Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Neurobo Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days Neurobo Pharmaceuticals has a beta of 0.1888 . This indicates as returns on the market go up, Neurobo Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Neurobo Pharmaceuticals will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Neurobo Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Neurobo Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Neurobo delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Neurobo Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Neurobo Pharmaceuticals Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Neurobo Pharmaceuticals Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Neurobo Pharmaceuticals is -931.24. The daily returns are distributed with a variance of 23.26 and standard deviation of 4.82. The mean deviation of Neurobo Pharmaceuticals is currently at 3.31. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.5 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 4.82 | |
Ir | Information ratio | -0.13 |
Neurobo Pharmaceuticals Stock Return Volatility
Neurobo Pharmaceuticals historical daily return volatility represents how much of Neurobo Pharmaceuticals delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 4.8225% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7502% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Neurobo Pharmaceuticals Volatility
Volatility is a rate at which the price of Neurobo Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Neurobo Pharmaceuticals may increase or decrease. In other words, similar to Neurobo's beta indicator, it measures the risk of Neurobo Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Neurobo Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. Neurobo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Neurobo Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Neurobo Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Neurobo Pharmaceuticals' price varies over time.
3 ways to utilize Neurobo Pharmaceuticals' volatility to invest better
Higher Neurobo Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Neurobo Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Neurobo Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Neurobo Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Neurobo Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Neurobo Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Neurobo Pharmaceuticals Investment Opportunity
Neurobo Pharmaceuticals has a volatility of 4.82 and is 6.43 times more volatile than Dow Jones Industrial. 42 percent of all equities and portfolios are less risky than Neurobo Pharmaceuticals. You can use Neurobo Pharmaceuticals to enhance the returns of your portfolios. The stock experiences a normal upward fluctuation. Check odds of Neurobo Pharmaceuticals to be traded at $2.48 in 90 days.Significant diversification
The correlation between Neurobo Pharmaceuticals and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Neurobo Pharmaceuticals Additional Risk Indicators
The analysis of Neurobo Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Neurobo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Neurobo Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (2.53) | |||
| Mean Deviation | 3.35 | |||
| Coefficient Of Variation | (1,023) | |||
| Standard Deviation | 4.8 | |||
| Variance | 23.01 | |||
| Information Ratio | (0.13) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Neurobo Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Neurobo Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Neurobo Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Neurobo Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Neurobo Pharmaceuticals.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurobo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Neurobo Stock
If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |